Clinical Studies

Randomized Pilot Study of a Keratin-based Topical Cream for Radiation Dermatitis in Breast Cancer Patients

This study shows the clinical benefits of using KeraStat Cream for breast cancer patients undergoing radiation therapy. Specifically, “the rate of RTOG Grade 2 RD was lower in the KC group (30.8%) compared to the SOC group (54.5%)”, and “patient-reported quality of life measured by the DLQI at the end of RT was improved in the KC group versus the SOC group.”

Winkfield et al. (2024)

https://doi.org/10.1177/15330338231222137